AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 32359506
Drug: Bortezomib-lenalidomide-dexamethasone (VRD)
RxNorm normalized name: Bortezomib
DrugBank: Bortezomib (DB00188)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bortezomib-lenalidomide-dexamethasone (VRD) consolidation therapy
Trial: 34527078
Drug: Eprosartan (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eprosartan (600 mg daily)
Trial: 33263418
Drug: Margetuximab plus
RxNorm normalized name: Margetuximab
DrugBank: Margetuximab (DB14967)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Margetuximab plus retifanlimab with/without chemotherapy
Trial: 33263418
Drug: Margetuximab plus
RxNorm normalized name: Margetuximab
DrugBank: Margetuximab (DB14967)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Margetuximab plus tebotelimab with chemotherapy
Trial: 34341242
Drug: Chemomechanical removal
RxNorm normalized name: Super Spot Remover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemomechanical removal (Papaya® gel)
Trial: 32372118
Drug: Intravenous TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous TXA (15 mg/kg)
Trial: 32372118
Drug: Intra-articular TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular TXA (2 g)
Trial: 34030169
Drug: Sertraline (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50 mg daily, up-titrated after 25 mg daily for 1 week)
Trial: 32029903
Drug: Naltrexone (NTX)
DrugBank: Naltrexone (DB00704)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naltrexone (NTX) treatment
Trial: 35781129
Drug: Single, high‐dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single, high‐dose intravenous iron therapy (20 mg/kg ferric derisomaltose)
Trial: 35781129
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron supplementation (100 mg ferrous sulphate orally twice daily)
Trial: 34684650
Drug: Water supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water supplementation group (1000 mL purified water)
Trial: 34684650
Drug: Water supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water supplementation group (500 mL purified water)
Trial: 34684650
Drug: Water supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water supplementation group (200 mL purified water)
Trial: 34618889
Drug: Preoperative paravertebral
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative paravertebral block with 0.35 ml/kg 0.75% ropivacaine
Trial: 32086874
Drug: Ethmoidal drug-eluting
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethmoidal drug-eluting stent (DES) with triamcinolone acetonide stents (n = 34)
Trial: 32086874
Drug: Topical intranasal
RxNorm normalized name: NALOXONE RESCUE KIT INTRANASAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical intranasal corticosteroid (triamcinolone acetonide nasal spray) (n = 29)
Trial: 34226654
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH, Genotonorm 0.4 mg, Pfizer Pharmaceuticals) administered subcutaneously daily for one year
Trial: 34226654
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered subcutaneously daily for one year
Trial: 35222690
Drug: 3D-slicer software-assisted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3D-slicer software-assisted endoscopic treatment
Trial: 32618242
Drug: Focal Mass
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Focal Mass Drug Administration (fMDA)
Trial: 32424833
Drug: Atraumatic Restorative
RxNorm normalized name: DRESSING,RESTORE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atraumatic Restorative Treatment and Hall crown approaches (ARTs)
Trial: 36975369
Drug: V160 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: V160 vaccine
Trial: 35599912
Drug: Pre-sleep protein
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein Injection [Arexvy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-sleep protein (PRO) supplement containing 40 g of casein protein (n=10)
Trial: 32441675
Drug: Nurse-provided education
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nurse-provided education about chemotherapy-associated taste disorders
Trial: 35251294
Drug: Anlotinib in
RxNorm normalized name: Anlotinib
DrugBank: Anlotinib (DB11885)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anlotinib in combination with other drugs
Trial: 35251294
Drug: Anlotinib monotherapy
RxNorm normalized name: Anlotinib
DrugBank: Anlotinib (DB11885)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anlotinib monotherapy
Trial: 35869707
Drug: Conventional Western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Western medical treatment
Trial: 35901983
Drug: Placebo delivery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo delivery (0 mg)
Trial: 35901983
Drug: Steady-state delivery
RxNorm normalized name: CLOZAPINE (GOLDEN STATE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steady-state delivery (2 mg)
Trial: 35901983
Drug: Random nicotine
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Random nicotine delivery (RND) (0 mg or 4 mg)
Trial: 32211998
Drug: Control (motor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (motor control training and manual therapy)
Trial: 34157312
Drug: 5 µg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 µg/d Cu-IUS
Trial: 34157312
Drug: 20 µg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 µg/d Cu-IUS
Trial: 34157312
Drug: 40 µg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 µg/d Cu-IUS
Trial: 35278356
Drug: Chemotherapy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy followed by chemotherapy plus durvalumab and tremelimumab
Trial: 35278356
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus durvalumab
Trial: 35278356
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus durvalumab and tremelimumab
Trial: 36321352
Drug: Potassium chloride
RxNorm normalized name: Potassium Chloride
DrugBank: Potassium chloride (DB00761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Potassium chloride (KCl) sustained-release tablets, oral dose of 6 g under fasting conditions
Trial: 36321352
Drug: Potassium chloride
RxNorm normalized name: Potassium Chloride
DrugBank: Potassium chloride (DB00761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Potassium chloride (KCl) sustained-release tablets, oral dose of 6 g under different dietary arrangements
Trial: 32383050
Drug: Mirtazapine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirtazapine (15 mg per day)
Trial: 32383050
Drug: Gabapentin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (100 mg per day)
Trial: 34858310
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of training and tDCS
Trial: 34867115
Drug: Intelligent training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intelligent training system, twice a day, 20 minutes each time.
Trial: 35857752
Drug: N-Acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-Acetylcysteine (NAC) 2 g daily
Trial: 33899191
Drug: 3g of
RxNorm normalized name: Oil of peppermint
DrugBank: Peppermint oil (DB11198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3g of magnesium sulfate in 100mL of glucose solution (Group A)
Trial: 33899191
Drug: 100 mL
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mL of glucose solution (Group B)
Trial: 35551291
Drug: PGDM1400, PGT121,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGDM1400, PGT121, and VRC07-523LS (20 mg kg−1 each)
Trial: 35751528
Drug: Rivaroxaban 2.5
RxNorm normalized name: rivaroxaban 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 2.5 mg b.i.d. plus aspirin 100 mg o.d.
Trial: 35751528
Drug: Aspirin 100
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 100 mg o.d.
Trial: 33029705
Drug: Folinic acid
RxNorm normalized name: Folinic acid
DrugBank: Leucovorin (DB00650)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Folinic acid (2 mg/kg up to 50 mg per day)
Trial: 35868342
Drug: Pay-it-forward intervention
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pay-it-forward intervention (free influenza vaccine and opportunity to donate)
Trial: 32933577
Drug: Ordinary PAP
RxNorm normalized name: ordinary salt combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ordinary PAP treatment at the health care centre (HCC group)
Trial: 35576638
Drug: 300 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/kg magnolol (M300)
Trial: 35576638
Drug: 300 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/kg honokiol (H300)
Trial: 35576638
Drug: 300 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/kg total phenols with a magnolol/honokiol ratio of 2:1 (M200H100)
Trial: 35576638
Drug: 300 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/kg total phenols with a magnolol/honokiol ratio of 1:2 (M100H200)
Trial: 35576638
Drug: 300 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/kg total phenols with a magnolol/honokiol ratio of 1:1 (M150H150)
Trial: 34704866
Drug: MindfulGarden (MG),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MindfulGarden (MG), a digital calming device, used during morning and evening care for 3 days, followed by exposure with verbal prompting on Day 4.
Trial: 35845514
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg esketamine, i.v.
Trial: 35845514
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg esketamine, i.v.
Trial: 34126044
Drug: Stereotactic body
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stereotactic body radiotherapy at a dose of 24 Gy in two daily fractions
Trial: 34126044
Drug: Conventional external
RxNorm normalized name: CATHETER,EXTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional external beam radiotherapy at a dose of 20 Gy in five daily fractions
Trial: 37133765
Drug: Functional Assessment
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional Assessment of Cancer Therapy‐Bladder Cancer (FACT‐BL)
Trial: 33620008
Drug: Topical LAA
RxNorm normalized name: LAAM
DrugBank: Levacetylmethadol (DB01227)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical LAA solution
Trial: 33710166
Drug: Light therapy
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light therapy for 12 weeks
Trial: 35835612
Drug: Intraperitoneal chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal chemotherapy (IP)
Trial: 32839221
Drug: RO7049389 (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RO7049389 (single dose of 150 to 2,500 mg)
Trial: 32839221
Drug: RO7049389 (multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RO7049389 (multiple doses of 200 to 800 mg)
Trial: 32839221
Drug: RO7049389 (450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RO7049389 (450 mg) under fasted and fed conditions
Trial: 32839221
Drug: RO7049389 (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RO7049389 (up to a single dose of 2,500 mg)
Trial: 34648192
Drug: Fluconazole (CYP2C19
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (CYP2C19 inhibitor)
Trial: 34648192
Drug: Ciprofloxacin (CYP1A2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (CYP1A2 inhibitor)
Trial: 34648192
Drug: Ciprofloxacin/Fluconazole (combination)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin/Fluconazole (combination)
Trial: 32753063
Drug: Paracetamol-diclofenac (1g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol-diclofenac (1g + 75mg)
Trial: 32753063
Drug: Paracetamol-tramadol (1g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol-tramadol (1g + 100mg)
Trial: 36858151
Drug: Apalutamide (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apalutamide (240 mg/day) plus ADT
Trial: 33400012
Drug: High-Intensity Laser
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Intensity Laser Therapy (HILT) + exercise
Trial: 35965421
Drug: Propolis (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propolis (300 mg)
Trial: 33326371
Drug: Prenatal vitamin
RxNorm normalized name: Prenatal Vitamins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenatal vitamin D supplementation (2 oral doses of 50,000 IU)
Trial: 33581259
Drug: Palonosetron (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron (all doses)
Trial: 32265083
Drug: Dexmedetomidine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine infusion (0.7 μg/kg/h in the operating room and 0.4 μg/kg/h in the ICU)
Trial: 35469330
Drug: Dexmedetomidine administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine administration
Trial: 35994795
Drug: Aromatherapy through
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aromatherapy through the skin and by inhalation
Trial: 34304467
Drug: Intratympanic injection
RxNorm normalized name: ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intratympanic injection of methylprednisolone (control group)
Trial: 32629078
Drug: Dose-escalated arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dose-escalated arm (up to 95 Gy prescribed to the tumor)
Trial: 32629078
Drug: Both arms
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both arms (dose constraints to organs at risk)
Trial: 36125170
Drug: Advertisement for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advertisement for a hypothetical cold sore medicine
Trial: 34537448
Drug: Bronchoscopic airway
RxNorm normalized name: inBreath airway transplant system
DrugBank: inBreath airway transplant system (DB18692)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchoscopic airway clearance therapy (B-ACT)
Trial: 34521593
Drug: 1,25-hydroxyvitamin D3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,25-hydroxyvitamin D3 plus amoxicillin, clarithromycin, and esomeprazole for 2 weeks
Trial: 34521593
Drug: Standard clarithromycin-based
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard clarithromycin-based triple therapy (amoxicillin, clarithromycin, and esomeprazole for 2 weeks)
Trial: 35129534
Drug: 4-day antibiotic
RxNorm normalized name: Antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-day antibiotic duration (experimental arm of STOP-IT RCT)
Trial: 35129534
Drug: Standard antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antibiotic duration (control group)
Trial: 36163806
Drug: Ivosidenib (IVO)
RxNorm normalized name: ivosidenib
DrugBank: Ivosidenib (DB14568)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivosidenib (IVO) 500 mg once daily plus Azacitidine (AZA) 75 mg/m2 for 7 days in 28-day cycles
Trial: 36163806
Drug: Placebo (PBO)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PBO) plus Azacitidine (AZA) 75 mg/m2 for 7 days in 28-day cycles
Trial: 34628889
Drug: ATD (methimazole,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATD (methimazole, 15-30 mg/day)
Trial: 36055467
Drug: H‐1337 Ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H‐1337 Ophthalmic Solution 0.06%
Trial: 36055467
Drug: H‐1337 Ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H‐1337 Ophthalmic Solution 0.20%
Trial: 36055467
Drug: H‐1337 Ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H‐1337 Ophthalmic Solution 0.60%
Trial: 36055467
Drug: H‐1337 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H‐1337 (all doses combined)
Trial: 33773189
Drug: Carvacrol (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvacrol (1.2 mg/kg/day, n = 17)
Trial: 34505292
Drug: 3-month psychological
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-month psychological intervention in addition to standard physiological treatment
Trial: 34505292
Drug: Standard physiological
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard physiological treatment
Trial: 35552364
Drug: Etirinotecan pegol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etirinotecan pegol, 145 mg/m2, every 21 days
Trial: 35552364
Drug: Chemotherapy (eribulin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (eribulin, ixabepilone, vinorelbine, gemcitabine, paclitaxel, docetaxel, or nab-paclitaxel)
Trial: 37465907
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 2400 mg/day
Trial: 35418247
Drug: Values-affirmation intervention
RxNorm normalized name: diphenhydramine hydrochloride Oral Capsule [Valu-Dryl]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Values-affirmation intervention on medication adherence
Trial: 33704444
Drug: ART (Antiretroviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ART (Antiretroviral Therapy)
Trial: 33176757
Drug: Hyperthermic baths
RxNorm normalized name: colloidal oatmeal
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperthermic baths (HTB) twice weekly for 8 weeks (n = 22)
Trial: 33176757
Drug: Physical exercise
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical exercise program (PEP) of moderate intensity twice weekly for 8 weeks (n = 23)
Trial: 35237338
Drug: Needle-warming moxibustion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needle-warming moxibustion combined with hyperbaric oxygen therapy (NWM + HBOT)
Trial: 35863947
Drug: 4 mL
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mL bolus every 45 min
Trial: 35863947
Drug: 6 mL
RxNorm normalized name: ethanol 0.6 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mL bolus every 45 min
Trial: 35863947
Drug: 8 mL
RxNorm normalized name: ethanol 0.8 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mL bolus every 45 min
Trial: 34238445
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg plus Ezetimibe 10 mg (ATO10/EZE10)
Trial: 34238445
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg alone (ATO40)
Trial: 35566482
Drug: Intravenous Ferric
RxNorm normalized name: Ferric Oxide
DrugBank: Ferric oxide (DB11576)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous Ferric Carboxymaltose (FCM)
Trial: 37257948
Drug: High-intensity care
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-intensity care with rapid uptitration of oral medications for heart failure
Trial: 36067063
Drug: Daratumumab subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daratumumab subcutaneous (DARA SC)
Trial: 36067063
Drug: Daratumumab intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daratumumab intravenous (DARA IV)
Trial: 33083852
Drug: Probiotic lozenges
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic lozenges (Lactobacillus brevis CD2)
Trial: 33514427
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose umbilical cord MSCs (200 × 10^6 cells, 3 infusions every other day for a total of 600 × 10^6 cells)
Trial: 33514427
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose placental MSCs (200 × 10^6 cells, 3 infusions every other day for a total of 600 × 10^6 cells)
Trial: 33514427
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose MSCs (both UC-MSCs and PL-MSCs)
Trial: 33507929
Drug: 0.5 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 ml/kg buccal 40% dextrose gel
Trial: 35954979
Drug: Exercise toolkit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise toolkit intervention (stick, theraband, sandbag, small ball) led by a physical therapist, 90 min per session, twice weekly for 3 months
Trial: 34803399
Drug: Transversus thoracic
RxNorm normalized name: Thoracol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transversus thoracic muscle plane block (TTPB) with general anesthesia (GA) and 15 mL of 0.25% bupivacaine
Trial: 34803399
Drug: Transversus thoracic
RxNorm normalized name: Thoracol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transversus thoracic muscle plane block (TTPB) with GA and 15 mL of 0.25% bupivacaine
Trial: 34803399
Drug: General anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anesthesia (GA) with saline injection
Trial: 32740972
Drug: Dexamethasone 6
RxNorm normalized name: dexamethasone 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 6 mg once per day for 10 days